Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Abrau-Durso reported for 6 months of 2024 by RAS

8/13/24 ABRD

Non-residents bought ₽8.1 billion worth of securities from private investors

8/13/24 MOEX

VK launched a service for tutors and learners

8/13/24 VKCO

Element will produce equipment for drones

8/13/24 ELMT

Board of Directors of Rostelecom recommended that dividends be paid for 2023

8/13/24 RTKM

Slavneft reported for 6 months of 2024 by RAS

8/13/24 SLAV

Aeroflot's passenger traffic grew by 14.7% in July

8/13/24 AFLT

TMK reported for 6 months of 2024 by IFRS

8/13/24 TRMK

Corporate Center X5 started distribution of shares

8/12/24 X5

Alrosa reported for 6 months of 2024 by RAS

8/12/24 ALRS